CANCER OF PANCREAS
Clinical trials for CANCER OF PANCREAS explained in plain language.
Never miss a new study
Get alerted when new CANCER OF PANCREAS trials appear
Sign up with your email to follow new studies for CANCER OF PANCREAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Cancer survivors get a new care team to tackle heart risks
Disease control OngoingThis study tests a new way to help cancer survivors manage other health problems like high blood pressure, diabetes, and high cholesterol. About 800 adults with certain cancers and at least one heart-related condition will be enrolled. Their primary care doctors will work more cl…
Matched conditions: CANCER OF PANCREAS
Phase: NA • Sponsor: Duke University • Aim: Disease control
Last updated May 17, 2026 07:06 UTC
-
New hope for Hard-to-Treat cancers: targeted drug enters human testing
Disease control OngoingThis early-phase study tests a new drug, HBI-2438, in people with advanced cancers (like lung, colon, or pancreatic) that have a specific genetic change called KRAS G12C. The main goal is to find the safest dose and check for side effects. About 44 adults who have tried other tre…
Matched conditions: CANCER OF PANCREAS
Phase: PHASE1 • Sponsor: HUYABIO International, LLC. • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New pill targets tough cancers: early trial begins
Disease control OngoingThis early-phase study tests an experimental oral drug, HBI-2376, in adults with advanced solid tumors (like lung, colon, or pancreatic cancer) that have specific KRAS or EGFR gene mutations. The main goal is to find the safest dose and check for side effects. About 42 participan…
Matched conditions: CANCER OF PANCREAS
Phase: PHASE1 • Sponsor: HUYABIO International, LLC. • Aim: Disease control
Last updated May 01, 2026 15:57 UTC